nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—liver cancer	0.417	0.556	CbGaD
Toremifene—CYP1A1—liver cancer	0.334	0.444	CbGaD
Toremifene—CYP1A2—Sorafenib—liver cancer	0.0277	0.308	CbGbCtD
Toremifene—ABCB1—Sorafenib—liver cancer	0.0242	0.269	CbGbCtD
Toremifene—ABCB1—Doxorubicin—liver cancer	0.0147	0.163	CbGbCtD
Toremifene—CYP3A4—Sorafenib—liver cancer	0.0145	0.161	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—liver cancer	0.00881	0.0979	CbGbCtD
Toremifene—Embolism—Sorafenib—liver cancer	0.00219	0.0338	CcSEcCtD
Toremifene—Leukorrhea—Epirubicin—liver cancer	0.00111	0.0171	CcSEcCtD
Toremifene—Cardiac failure—Sorafenib—liver cancer	0.00105	0.0162	CcSEcCtD
Toremifene—Leukorrhea—Doxorubicin—liver cancer	0.00103	0.0158	CcSEcCtD
Toremifene—Mood swings—Sorafenib—liver cancer	0.000968	0.0149	CcSEcCtD
Toremifene—Breast disorder—Sorafenib—liver cancer	0.000924	0.0143	CcSEcCtD
Toremifene—Polyp—Epirubicin—liver cancer	0.000855	0.0132	CcSEcCtD
Toremifene—Vaginal discharge—Epirubicin—liver cancer	0.000855	0.0132	CcSEcCtD
Toremifene—Embolism—Epirubicin—liver cancer	0.000811	0.0125	CcSEcCtD
Toremifene—Vaginal discharge—Doxorubicin—liver cancer	0.000791	0.0122	CcSEcCtD
Toremifene—Polyp—Doxorubicin—liver cancer	0.000791	0.0122	CcSEcCtD
Toremifene—Cyst—Epirubicin—liver cancer	0.000778	0.012	CcSEcCtD
Toremifene—Acute coronary syndrome—Sorafenib—liver cancer	0.000776	0.012	CcSEcCtD
Toremifene—Neuropathy peripheral—Sorafenib—liver cancer	0.000772	0.0119	CcSEcCtD
Toremifene—Myocardial infarction—Sorafenib—liver cancer	0.000772	0.0119	CcSEcCtD
Toremifene—Jaundice—Sorafenib—liver cancer	0.000768	0.0118	CcSEcCtD
Toremifene—Ospemifene—ESR1—liver cancer	0.000758	0.254	CrCbGaD
Toremifene—Embolism—Doxorubicin—liver cancer	0.00075	0.0116	CcSEcCtD
Toremifene—Hypercalcaemia—Epirubicin—liver cancer	0.000749	0.0116	CcSEcCtD
Toremifene—Hepatobiliary disease—Sorafenib—liver cancer	0.000745	0.0115	CcSEcCtD
Toremifene—Thrombosis—Epirubicin—liver cancer	0.000735	0.0113	CcSEcCtD
Toremifene—Cyst—Doxorubicin—liver cancer	0.00072	0.0111	CcSEcCtD
Toremifene—Vaginal haemorrhage—Epirubicin—liver cancer	0.000703	0.0108	CcSEcCtD
Toremifene—Hypercalcaemia—Doxorubicin—liver cancer	0.000693	0.0107	CcSEcCtD
Toremifene—Thrombosis—Doxorubicin—liver cancer	0.00068	0.0105	CcSEcCtD
Toremifene—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000651	0.01	CcSEcCtD
Toremifene—Angiopathy—Sorafenib—liver cancer	0.000642	0.0099	CcSEcCtD
Toremifene—Rigors—Epirubicin—liver cancer	0.000637	0.00984	CcSEcCtD
Toremifene—Mediastinal disorder—Sorafenib—liver cancer	0.000637	0.00983	CcSEcCtD
Toremifene—Arrhythmia—Sorafenib—liver cancer	0.000632	0.00975	CcSEcCtD
Toremifene—Alopecia—Sorafenib—liver cancer	0.000625	0.00964	CcSEcCtD
Toremifene—Mental disorder—Sorafenib—liver cancer	0.00062	0.00956	CcSEcCtD
Toremifene—Malnutrition—Sorafenib—liver cancer	0.000616	0.0095	CcSEcCtD
Toremifene—Rigors—Doxorubicin—liver cancer	0.00059	0.0091	CcSEcCtD
Toremifene—Skin discolouration—Epirubicin—liver cancer	0.000576	0.00889	CcSEcCtD
Toremifene—Leukopenia—Sorafenib—liver cancer	0.000551	0.0085	CcSEcCtD
Toremifene—Clomifene—ESR1—liver cancer	0.000534	0.179	CrCbGaD
Toremifene—Skin discolouration—Doxorubicin—liver cancer	0.000533	0.00823	CcSEcCtD
Toremifene—Coordination abnormal—Epirubicin—liver cancer	0.00053	0.00818	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00052	0.00803	CcSEcCtD
Toremifene—Hepatocellular injury—Epirubicin—liver cancer	0.00052	0.00803	CcSEcCtD
Toremifene—Pulmonary embolism—Epirubicin—liver cancer	0.00052	0.00803	CcSEcCtD
Toremifene—Nervous system disorder—Sorafenib—liver cancer	0.000493	0.0076	CcSEcCtD
Toremifene—Thrombocytopenia—Sorafenib—liver cancer	0.000492	0.00759	CcSEcCtD
Toremifene—Coordination abnormal—Doxorubicin—liver cancer	0.00049	0.00757	CcSEcCtD
Toremifene—Skin disorder—Sorafenib—liver cancer	0.000488	0.00753	CcSEcCtD
Toremifene—Hepatocellular injury—Doxorubicin—liver cancer	0.000482	0.00743	CcSEcCtD
Toremifene—Pulmonary embolism—Doxorubicin—liver cancer	0.000482	0.00743	CcSEcCtD
Toremifene—Dry eye—Epirubicin—liver cancer	0.000481	0.00742	CcSEcCtD
Toremifene—Anorexia—Sorafenib—liver cancer	0.000479	0.00739	CcSEcCtD
Toremifene—Abnormal vision—Epirubicin—liver cancer	0.000454	0.007	CcSEcCtD
Toremifene—Dyspnoea—Sorafenib—liver cancer	0.000448	0.00691	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—liver cancer	0.000445	0.00686	CcSEcCtD
Toremifene—Decreased appetite—Sorafenib—liver cancer	0.000437	0.00674	CcSEcCtD
Toremifene—Thrombophlebitis—Epirubicin—liver cancer	0.000436	0.00673	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sorafenib—liver cancer	0.000434	0.00669	CcSEcCtD
Toremifene—Fatigue—Sorafenib—liver cancer	0.000433	0.00668	CcSEcCtD
Toremifene—Clomifene—CYP2E1—liver cancer	0.000433	0.145	CrCbGaD
Toremifene—Pain—Sorafenib—liver cancer	0.00043	0.00663	CcSEcCtD
Toremifene—Constipation—Sorafenib—liver cancer	0.00043	0.00663	CcSEcCtD
Toremifene—Clomifene—CYP1A1—liver cancer	0.000427	0.143	CrCbGaD
Toremifene—Abnormal vision—Doxorubicin—liver cancer	0.00042	0.00648	CcSEcCtD
Toremifene—Hot flush—Epirubicin—liver cancer	0.000404	0.00623	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—liver cancer	0.000404	0.00623	CcSEcCtD
Toremifene—Menopausal symptoms—Epirubicin—liver cancer	0.0004	0.00618	CcSEcCtD
Toremifene—Cardiac failure—Epirubicin—liver cancer	0.000387	0.00597	CcSEcCtD
Toremifene—Lethargy—Epirubicin—liver cancer	0.000385	0.00595	CcSEcCtD
Toremifene—Diplopia—Epirubicin—liver cancer	0.000378	0.00583	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—liver cancer	0.000374	0.00577	CcSEcCtD
Toremifene—Affect lability—Epirubicin—liver cancer	0.000372	0.00574	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—liver cancer	0.00037	0.00572	CcSEcCtD
Toremifene—Asthenia—Sorafenib—liver cancer	0.00036	0.00556	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—liver cancer	0.000358	0.00553	CcSEcCtD
Toremifene—Mood swings—Epirubicin—liver cancer	0.000358	0.00552	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—liver cancer	0.000357	0.0055	CcSEcCtD
Toremifene—Pruritus—Sorafenib—liver cancer	0.000355	0.00548	CcSEcCtD
Toremifene—Ataxia—Epirubicin—liver cancer	0.000355	0.00548	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—liver cancer	0.00035	0.00539	CcSEcCtD
Toremifene—Liver function test abnormal—Epirubicin—liver cancer	0.000349	0.00538	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—liver cancer	0.000344	0.00531	CcSEcCtD
Toremifene—Breast disorder—Epirubicin—liver cancer	0.000341	0.00527	CcSEcCtD
Toremifene—Dizziness—Sorafenib—liver cancer	0.000332	0.00513	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—liver cancer	0.000331	0.00511	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—liver cancer	0.000329	0.00507	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—liver cancer	0.000323	0.00498	CcSEcCtD
Toremifene—Vomiting—Sorafenib—liver cancer	0.000319	0.00493	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—liver cancer	0.000318	0.00491	CcSEcCtD
Toremifene—Rash—Sorafenib—liver cancer	0.000317	0.00489	CcSEcCtD
Toremifene—Dermatitis—Sorafenib—liver cancer	0.000316	0.00488	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—liver cancer	0.000316	0.00487	CcSEcCtD
Toremifene—Headache—Sorafenib—liver cancer	0.000315	0.00486	CcSEcCtD
Toremifene—Nausea—Sorafenib—liver cancer	0.000298	0.0046	CcSEcCtD
Toremifene—Weight increased—Epirubicin—liver cancer	0.000297	0.00459	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—liver cancer	0.000294	0.00454	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—liver cancer	0.000285	0.0044	CcSEcCtD
Toremifene—Jaundice—Epirubicin—liver cancer	0.000284	0.00438	CcSEcCtD
Toremifene—Sweating—Epirubicin—liver cancer	0.000279	0.00431	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—liver cancer	0.000275	0.00425	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—liver cancer	0.000275	0.00424	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—liver cancer	0.000264	0.00407	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—liver cancer	0.000263	0.00405	CcSEcCtD
Toremifene—Sweating—Doxorubicin—liver cancer	0.000258	0.00398	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—liver cancer	0.000255	0.00393	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—liver cancer	0.000252	0.00389	CcSEcCtD
Toremifene—Tamoxifen—ESR1—liver cancer	0.000247	0.0825	CrCbGaD
Toremifene—Eye disorder—Epirubicin—liver cancer	0.000244	0.00377	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—liver cancer	0.000237	0.00366	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—liver cancer	0.000236	0.00363	CcSEcCtD
Toremifene—Chills—Epirubicin—liver cancer	0.000234	0.00362	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—liver cancer	0.000233	0.0036	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—liver cancer	0.000233	0.0036	CcSEcCtD
Toremifene—Alopecia—Epirubicin—liver cancer	0.000231	0.00356	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—liver cancer	0.000229	0.00353	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—liver cancer	0.000227	0.00351	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—liver cancer	0.000226	0.00349	CcSEcCtD
Toremifene—Back pain—Epirubicin—liver cancer	0.00022	0.0034	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—liver cancer	0.000219	0.00339	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—liver cancer	0.000218	0.00336	CcSEcCtD
Toremifene—Chills—Doxorubicin—liver cancer	0.000217	0.00335	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—liver cancer	0.000216	0.00333	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—liver cancer	0.000214	0.00331	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—liver cancer	0.000214	0.0033	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—liver cancer	0.000212	0.00327	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—liver cancer	0.00021	0.00325	CcSEcCtD
Toremifene—Vertigo—Epirubicin—liver cancer	0.000204	0.00315	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—liver cancer	0.000204	0.00314	CcSEcCtD
Toremifene—Back pain—Doxorubicin—liver cancer	0.000204	0.00314	CcSEcCtD
Toremifene—Tamoxifen—CYP2E1—liver cancer	0.0002	0.0669	CrCbGaD
Toremifene—Vision blurred—Doxorubicin—liver cancer	0.000198	0.00306	CcSEcCtD
Toremifene—Tamoxifen—CYP1A1—liver cancer	0.000197	0.066	CrCbGaD
Toremifene—Orphenadrine—CYP2E1—liver cancer	0.000194	0.065	CrCbGaD
Toremifene—Chest pain—Epirubicin—liver cancer	0.000194	0.00299	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000192	0.00297	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—liver cancer	0.000189	0.00292	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—liver cancer	0.000188	0.00291	CcSEcCtD
Toremifene—Oedema—Epirubicin—liver cancer	0.000186	0.00287	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—liver cancer	0.000182	0.00281	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—liver cancer	0.000182	0.00281	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—liver cancer	0.00018	0.00278	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—liver cancer	0.000179	0.00277	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—liver cancer	0.000179	0.00277	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000178	0.00275	CcSEcCtD
Toremifene—Anorexia—Epirubicin—liver cancer	0.000177	0.00273	CcSEcCtD
Toremifene—Oedema—Doxorubicin—liver cancer	0.000172	0.00265	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—liver cancer	0.000168	0.0026	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—liver cancer	0.000168	0.0026	CcSEcCtD
Toremifene—Insomnia—Epirubicin—liver cancer	0.000168	0.00259	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—liver cancer	0.000167	0.00257	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—liver cancer	0.000166	0.00256	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—liver cancer	0.000166	0.00255	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—liver cancer	0.000164	0.00253	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—liver cancer	0.000161	0.00249	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—liver cancer	0.00016	0.00247	CcSEcCtD
Toremifene—Fatigue—Epirubicin—liver cancer	0.00016	0.00247	CcSEcCtD
Toremifene—Pain—Epirubicin—liver cancer	0.000159	0.00245	CcSEcCtD
Toremifene—Constipation—Epirubicin—liver cancer	0.000159	0.00245	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—liver cancer	0.000155	0.0024	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—liver cancer	0.000153	0.00236	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—liver cancer	0.000149	0.0023	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000148	0.00229	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—liver cancer	0.000148	0.00229	CcSEcCtD
Toremifene—Constipation—Doxorubicin—liver cancer	0.000147	0.00227	CcSEcCtD
Toremifene—Pain—Doxorubicin—liver cancer	0.000147	0.00227	CcSEcCtD
Toremifene—Asthenia—Epirubicin—liver cancer	0.000133	0.00206	CcSEcCtD
Toremifene—Pruritus—Epirubicin—liver cancer	0.000131	0.00203	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—liver cancer	0.000123	0.0019	CcSEcCtD
Toremifene—Dizziness—Epirubicin—liver cancer	0.000123	0.00189	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—liver cancer	0.000122	0.00188	CcSEcCtD
Toremifene—Vomiting—Epirubicin—liver cancer	0.000118	0.00182	CcSEcCtD
Toremifene—Rash—Epirubicin—liver cancer	0.000117	0.00181	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—liver cancer	0.000117	0.0018	CcSEcCtD
Toremifene—Headache—Epirubicin—liver cancer	0.000116	0.00179	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—liver cancer	0.000114	0.00175	CcSEcCtD
Toremifene—Nausea—Epirubicin—liver cancer	0.00011	0.0017	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—liver cancer	0.000109	0.00169	CcSEcCtD
Toremifene—Rash—Doxorubicin—liver cancer	0.000108	0.00167	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—liver cancer	0.000108	0.00167	CcSEcCtD
Toremifene—Headache—Doxorubicin—liver cancer	0.000108	0.00166	CcSEcCtD
Toremifene—Nausea—Doxorubicin—liver cancer	0.000102	0.00157	CcSEcCtD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	4.39e-05	0.000479	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—liver cancer	4.32e-05	0.000471	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	4.31e-05	0.00047	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	4.24e-05	0.000462	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—liver cancer	4.24e-05	0.000462	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—UGDH—liver cancer	4.23e-05	0.000462	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	4.23e-05	0.000461	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—liver cancer	4.2e-05	0.000458	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HNF4A—liver cancer	4.1e-05	0.000447	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	4.08e-05	0.000445	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTP1—liver cancer	4e-05	0.000437	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—liver cancer	4e-05	0.000436	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EPT1—liver cancer	3.98e-05	0.000434	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.95e-05	0.000431	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	3.95e-05	0.000431	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.92e-05	0.000427	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—liver cancer	3.83e-05	0.000417	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TAT—liver cancer	3.77e-05	0.000411	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—liver cancer	3.7e-05	0.000403	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.68e-05	0.000401	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	3.64e-05	0.000397	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.63e-05	0.000396	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.6e-05	0.000393	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PSMA4—liver cancer	3.58e-05	0.00039	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PSMD10—liver cancer	3.58e-05	0.00039	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—liver cancer	3.55e-05	0.000387	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—liver cancer	3.53e-05	0.000385	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.49e-05	0.00038	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.48e-05	0.00038	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.48e-05	0.000379	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.44e-05	0.000375	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FST—liver cancer	3.43e-05	0.000374	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	3.39e-05	0.00037	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—UGDH—liver cancer	3.38e-05	0.000369	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—SERPINE1—liver cancer	3.33e-05	0.000363	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TRIO—liver cancer	3.27e-05	0.000356	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GLUL—liver cancer	3.21e-05	0.00035	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CPT1B—liver cancer	3.21e-05	0.00035	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	3.2e-05	0.000349	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EPT1—liver cancer	3.18e-05	0.000347	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR4—liver cancer	3.13e-05	0.000342	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NR1H4—liver cancer	3.1e-05	0.000338	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTA3—liver cancer	3.05e-05	0.000332	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TAT—liver cancer	3.01e-05	0.000328	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.96e-05	0.000323	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.94e-05	0.000321	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	2.93e-05	0.00032	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	2.87e-05	0.000313	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	2.8e-05	0.000305	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	2.79e-05	0.000304	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTA4—liver cancer	2.79e-05	0.000304	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	2.77e-05	0.000302	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTA2—liver cancer	2.71e-05	0.000296	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	2.71e-05	0.000295	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	2.69e-05	0.000294	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	2.64e-05	0.000288	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTA1—liver cancer	2.62e-05	0.000285	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UGDH—liver cancer	2.61e-05	0.000284	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NAT2—liver cancer	2.59e-05	0.000282	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CPT1B—liver cancer	2.57e-05	0.00028	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GLUL—liver cancer	2.57e-05	0.00028	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.49e-05	0.000271	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALDOB—liver cancer	2.48e-05	0.000271	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADAM17—liver cancer	2.48e-05	0.00027	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NR1H4—liver cancer	2.47e-05	0.00027	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EPT1—liver cancer	2.45e-05	0.000267	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.44e-05	0.000266	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA3—liver cancer	2.43e-05	0.000265	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—H2AFX—liver cancer	2.42e-05	0.000264	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CRABP1—liver cancer	2.37e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.34e-05	0.000255	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSMA4—liver cancer	2.33e-05	0.000254	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSMD10—liver cancer	2.33e-05	0.000254	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TAT—liver cancer	2.33e-05	0.000254	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.24e-05	0.000245	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.24e-05	0.000244	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA4—liver cancer	2.22e-05	0.000243	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.22e-05	0.000242	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA2—liver cancer	2.17e-05	0.000236	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARA—liver cancer	2.15e-05	0.000235	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.13e-05	0.000232	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—liver cancer	2.11e-05	0.00023	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA1—liver cancer	2.09e-05	0.000228	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.09e-05	0.000228	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.07e-05	0.000226	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HPGDS—liver cancer	2.07e-05	0.000226	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAT2—liver cancer	2.07e-05	0.000225	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.06e-05	0.000224	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CPT1B—liver cancer	2.05e-05	0.000223	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GLUL—liver cancer	2.05e-05	0.000223	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK14—liver cancer	1.99e-05	0.000217	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDOB—liver cancer	1.98e-05	0.000216	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NR1H4—liver cancer	1.97e-05	0.000215	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA3—liver cancer	1.94e-05	0.000212	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.91e-05	0.000208	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CRABP1—liver cancer	1.89e-05	0.000206	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.89e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.87e-05	0.000204	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.85e-05	0.000202	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSMA4—liver cancer	1.84e-05	0.000201	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSMD10—liver cancer	1.84e-05	0.000201	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.84e-05	0.000201	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCE—liver cancer	1.8e-05	0.000197	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GOT2—liver cancer	1.79e-05	0.000196	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—liver cancer	1.78e-05	0.000194	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA4—liver cancer	1.78e-05	0.000194	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.74e-05	0.000189	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA2—liver cancer	1.73e-05	0.000189	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—liver cancer	1.71e-05	0.000186	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2E1—liver cancer	1.69e-05	0.000184	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA1—liver cancer	1.67e-05	0.000182	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HPGDS—liver cancer	1.65e-05	0.00018	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAT2—liver cancer	1.65e-05	0.00018	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.63e-05	0.000178	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—liver cancer	1.6e-05	0.000175	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CSF2—liver cancer	1.6e-05	0.000174	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.59e-05	0.000173	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDOB—liver cancer	1.58e-05	0.000173	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CPT1B—liver cancer	1.58e-05	0.000172	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GLUL—liver cancer	1.58e-05	0.000172	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYCS—liver cancer	1.58e-05	0.000172	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—H2AFX—liver cancer	1.57e-05	0.000171	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.56e-05	0.00017	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GOT1—liver cancer	1.55e-05	0.000169	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GGT1—liver cancer	1.55e-05	0.000169	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NR1H4—liver cancer	1.52e-05	0.000166	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CRABP1—liver cancer	1.51e-05	0.000165	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA3—liver cancer	1.5e-05	0.000163	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMA4—liver cancer	1.47e-05	0.000161	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMD10—liver cancer	1.47e-05	0.000161	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT2—liver cancer	1.43e-05	0.000156	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—liver cancer	1.42e-05	0.000155	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.41e-05	0.000153	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—liver cancer	1.39e-05	0.000152	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—liver cancer	1.37e-05	0.00015	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA4—liver cancer	1.37e-05	0.000149	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.36e-05	0.000148	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—liver cancer	1.35e-05	0.000147	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA2—liver cancer	1.34e-05	0.000146	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HPGDS—liver cancer	1.32e-05	0.000144	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.31e-05	0.000143	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—liver cancer	1.3e-05	0.000142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK14—liver cancer	1.29e-05	0.000141	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA1—liver cancer	1.29e-05	0.00014	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—liver cancer	1.28e-05	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAT2—liver cancer	1.27e-05	0.000139	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.27e-05	0.000139	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYCS—liver cancer	1.26e-05	0.000137	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—liver cancer	1.25e-05	0.000137	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT1—liver cancer	1.24e-05	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GGT1—liver cancer	1.24e-05	0.000135	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDOB—liver cancer	1.22e-05	0.000133	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.2e-05	0.000131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—liver cancer	1.2e-05	0.000131	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.2e-05	0.00013	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.18e-05	0.000129	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMA4—liver cancer	1.18e-05	0.000128	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMD10—liver cancer	1.18e-05	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CRABP1—liver cancer	1.17e-05	0.000127	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT2—liver cancer	1.14e-05	0.000125	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—liver cancer	1.13e-05	0.000123	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—liver cancer	1.13e-05	0.000123	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—liver cancer	1.11e-05	0.000121	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARA—liver cancer	1.11e-05	0.000121	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—liver cancer	1.1e-05	0.00012	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—liver cancer	1.08e-05	0.000117	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.05e-05	0.000115	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.04e-05	0.000114	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.04e-05	0.000114	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—liver cancer	1.02e-05	0.000111	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPGDS—liver cancer	1.02e-05	0.000111	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—liver cancer	1.01e-05	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYCS—liver cancer	1.01e-05	0.00011	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.96e-06	0.000109	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GGT1—liver cancer	9.88e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT1—liver cancer	9.88e-06	0.000108	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—liver cancer	9.68e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—liver cancer	9.5e-06	0.000104	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAF1—liver cancer	9.41e-06	0.000103	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—liver cancer	9.18e-06	0.0001	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—liver cancer	9.18e-06	0.0001	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—liver cancer	9.16e-06	9.99e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMD10—liver cancer	9.08e-06	9.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMA4—liver cancer	9.08e-06	9.9e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—liver cancer	9.03e-06	9.84e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—liver cancer	8.87e-06	9.67e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARA—liver cancer	8.86e-06	9.65e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT2—liver cancer	8.83e-06	9.63e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—liver cancer	8.75e-06	9.54e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—liver cancer	8.62e-06	9.4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—liver cancer	8.45e-06	9.21e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—liver cancer	8.43e-06	9.2e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—liver cancer	8.35e-06	9.1e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—liver cancer	8.3e-06	9.05e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—liver cancer	8.24e-06	8.98e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—liver cancer	8.22e-06	8.96e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUN—liver cancer	8.21e-06	8.95e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—liver cancer	8.15e-06	8.89e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—liver cancer	8.14e-06	8.88e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—liver cancer	7.98e-06	8.7e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—liver cancer	7.95e-06	8.67e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYCS—liver cancer	7.77e-06	8.47e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—liver cancer	7.76e-06	8.46e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—liver cancer	7.73e-06	8.43e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT1—liver cancer	7.62e-06	8.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GGT1—liver cancer	7.62e-06	8.31e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—liver cancer	7.58e-06	8.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—liver cancer	7.32e-06	7.98e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—liver cancer	7.28e-06	7.93e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—liver cancer	7.21e-06	7.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—liver cancer	7.17e-06	7.82e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—liver cancer	7.1e-06	7.74e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARA—liver cancer	7.07e-06	7.71e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—liver cancer	7.03e-06	7.67e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—liver cancer	6.85e-06	7.47e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—liver cancer	6.75e-06	7.36e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—liver cancer	6.67e-06	7.27e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—liver cancer	6.6e-06	7.19e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—liver cancer	6.58e-06	7.18e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—liver cancer	6.58e-06	7.17e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.35e-06	6.92e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—liver cancer	6.29e-06	6.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—liver cancer	6.09e-06	6.64e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—liver cancer	6.05e-06	6.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—liver cancer	5.97e-06	6.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—liver cancer	5.84e-06	6.37e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—liver cancer	5.81e-06	6.34e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—liver cancer	5.6e-06	6.1e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—liver cancer	5.56e-06	6.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARA—liver cancer	5.46e-06	5.95e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—liver cancer	5.42e-06	5.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—liver cancer	5.32e-06	5.8e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—liver cancer	5.25e-06	5.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—liver cancer	5.18e-06	5.65e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—liver cancer	4.96e-06	5.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—liver cancer	4.67e-06	5.09e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—liver cancer	4.64e-06	5.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—liver cancer	4.57e-06	4.99e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—liver cancer	4.51e-06	4.92e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—liver cancer	4.44e-06	4.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—liver cancer	4.11e-06	4.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—liver cancer	4.06e-06	4.42e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—liver cancer	3.62e-06	3.95e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—liver cancer	3.58e-06	3.9e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—liver cancer	3.54e-06	3.86e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—liver cancer	2.89e-06	3.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—liver cancer	2.83e-06	3.08e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—liver cancer	2.31e-06	2.52e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—liver cancer	2.18e-06	2.38e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—liver cancer	1.78e-06	1.94e-05	CbGpPWpGaD
